| Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8 (4), 445-544, 2012 | 14168* | 2012 |
| The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24 EG Caudell, JB Mumm, N Poindexter, S Ekmekcioglu, AM Mhashilkar, ... The Journal of immunology 168 (12), 6041-6046, 2002 | 438 | 2002 |
| Oncogenic BRAF (V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma JS Khalili, S Liu, TG Rodríguez-Cruz, M Whittington, S Wardell, C Liu, ... Clinical Cancer Research 18 (19), 5329-5340, 2012 | 335 | 2012 |
| Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma JA Ellerhorst, VR Greene, S Ekmekcioglu, CL Warneke, MM Johnson, ... Clinical Cancer Research 17 (2), 229-235, 2011 | 314 | 2011 |
| Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer … AW Tong, J Nemunaitis, D Su, Y Zhang, C Cunningham, N Senzer, ... Molecular therapy 11 (1), 160-172, 2005 | 277 | 2005 |
| Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival S Ekmekcioglu, J Ellerhorst, CM Smid, VG Prieto, M Munsell, AC Buzaid, ... Clinical Cancer Research 6 (12), 4768-4775, 2000 | 267 | 2000 |
| Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Y Hailemichael, DH Johnson, N Abdel-Wahab, WC Foo, SE Bentebibel, ... Cancer Cell 40 (5), 509-523. e6, 2022 | 226 | 2022 |
| Loss of MDA-7 expression with progression of melanoma JA Ellerhorst, VG Prieto, S Ekmekcioglu, L Broemeling, S Yekell, S Chada, ... Journal of clinical oncology 20 (4), 1069-1074, 2002 | 192 | 2002 |
| Inhibition of nuclear factor-κB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells M Zheng, S Ekmekcioglu, ET Walch, CH Tang, EA Grimm Melanoma research 14 (3), 165-171, 2004 | 187 | 2004 |
| MDA-7/IL-24 is a unique cytokine–tumor suppressor in the IL-10 family S Chada, RB Sutton, S Ekmekcioglu, J Ellerhorst, JB Mumm, WW Leitner, ... International immunopharmacology 4 (5), 649-667, 2004 | 181 | 2004 |
| Tumor iNOS predicts poor survival for stage III melanoma patients S Ekmekcioglu, JA Ellerhorst, VG Prieto, MM Johnson, LD Broemeling, ... International journal of cancer 119 (4), 861-866, 2006 | 171 | 2006 |
| Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma P Bailey, DK Chang, MA Forget, FAS Lucas, HA Alvarez, C Haymaker, ... Scientific reports 6 (1), 35848, 2016 | 162 | 2016 |
| Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas S Ekmekcioglu, J Ellerhorst, AM Mhashilkar, AA Sahin, CM Read, ... International journal of cancer 94 (1), 54-59, 2001 | 155 | 2001 |
| Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy AG Sikora, A Gelbard, MA Davies, D Sano, S Ekmekcioglu, J Kwon, ... Clinical cancer research 16 (6), 1834-1844, 2010 | 149 | 2010 |
| Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism S Chada, AM Mhashilkar, R Ramesh, JB Mumm, RB Sutton, D Bocangel, ... Molecular therapy 10 (6), 1085-1095, 2004 | 148 | 2004 |
| Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy SH Kim, J Roszik, EA Grimm, S Ekmekcioglu Frontiers in oncology 8, 67, 2018 | 144 | 2018 |
| Implications of tissue transglutaminase expression in malignant melanoma JY Fok, S Ekmekcioglu, K Mehta Molecular cancer therapeutics 5 (6), 1493-1503, 2006 | 135 | 2006 |
| PI3K blockade by Ad-PTEN inhibits invasion and induces apoptosis in radial growth phase and metastatic melanoma cells AL Stewart, AM Mhashilkar, XH Yang, S Ekmekcioglu, Y Saito, K Sieger, ... Molecular medicine 8, 451-461, 2002 | 123 | 2002 |
| Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2 E Lopez-Rivera, P Jayaraman, F Parikh, MA Davies, S Ekmekcioglu, ... Cancer research 74 (4), 1067-1078, 2014 | 116 | 2014 |
| Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma Y Qin, S Ekmekcioglu, P Liu, LM Duncan, G Lizée, N Poindexter, ... Molecular Cancer Research 9 (11), 1537-1550, 2011 | 104 | 2011 |
Elizabeth GrimmProfessor, University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org